This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Douglas Micalizzi: Innovator in Cancer Research
Introduction
Douglas Micalizzi is a prominent inventor based in Somerville, MA (US). He has made significant contributions to the field of cancer research, particularly through his innovative patent. His work focuses on therapeutic strategies that target specific proteins involved in cancer progression.
Latest Patents
Micalizzi holds a patent titled "Therapeutic Targeting of Cadherin 11 in Cancer." This patent represents a crucial advancement in the development of targeted therapies for cancer treatment. The innovation aims to improve patient outcomes by specifically addressing the role of Cadherin 11 in tumor biology.
Career Highlights
Douglas Micalizzi is affiliated with Brigham and Women's Hospital, Inc., where he conducts his research. His work is characterized by a commitment to advancing cancer therapies and improving the understanding of cancer biology. Micalizzi's contributions have been recognized within the scientific community, underscoring his role as a leading figure in cancer research.
Collaborations
Micalizzi collaborates with esteemed colleagues, including Daniel A. Haber, who is also a notable figure in cancer research. Their partnership exemplifies the collaborative spirit of scientific inquiry, which is essential for driving innovation in the field.
Conclusion
Douglas Micalizzi's work in cancer research, particularly through his patent on therapeutic targeting, highlights his dedication to improving cancer treatment. His contributions continue to influence the landscape of cancer therapies and research.